Correction: H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. [PDF]
Lee E, Park YJ, Lindroth AM.
europepmc +1 more source
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius. [PDF]
Li Z +6 more
europepmc +1 more source
Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study. [PDF]
Xu H +29 more
europepmc +1 more source
The successful control of multiple pulmonary metastasis from giant cell tumor of bone by monthly denosumab administration: A case report. [PDF]
Liu Y, Liu M, Ye Z, Li H.
europepmc +1 more source
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment. [PDF]
Wu HL, Wang XB, Li J, Zheng BW.
europepmc +1 more source
GIANT CELL TUMOR OF BONE: A MULTICENTER EPIDEMIOLOGICAL STUDY IN BRAZIL. [PDF]
Becker RG +5 more
europepmc +1 more source
Excision of a Giant Cell Tumor With Bone Grafting and Bone Cementing of the Proximal Humerus: A Case Report. [PDF]
Gharpinde MR +4 more
europepmc +1 more source
H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2. [PDF]
Lee E, Park YJ, Lindroth AM.
europepmc +1 more source

